Citeline Elevate_732x655
Commercial FREE EVENT

Citeline Elevate: Winning Commercial Strategies

Perfect for: Anyone with an interest in the commercial aspects of pharma, from pipeline predictions to cash flow and innovation, led by industry experts and pharma voices.

Citeline Elevate Agenda

NOV 16, 2023
11am BST

11:00 AM - 11:20 AM GMT | Registration & Networking Drinks

NOV 16, 2023
11am EDT

11:20 AM - 11:30 AM GMT | Opening remarks

HOSTED BY
  • M Hay
    Michael Hay General Manager, Strategic Intelligence, Citeline
  • Alongside a panel of... 
NOV 16, 2023
11am BST

11:30 AM - 12:00 PM GMT | Session 1 - Fireside chat

HOSTED BY
  • L Ellis Taitt
    Lucie Ellis-Taitt Executive Director, In Vivo
  • J-P Hennebelle
    Jean-Patrick Hennebelle SVP and Head of Late-Stage Partnering at IPSEN
  • Alongside a panel of...
NOV 16, 2023
12pm BST

12:00 PM - 12:30 PM GMT | Session 2 - Citeline Keynote: Pharmaceutical Futurology and Pipeline Prediction

HOSTED BY
  • D Chancellor
    Daniel Chancellor Director, Thought Leadership and Consulting, Citeline
  • Alongside a panel of...
NOV 16, 2023
12pm BST

12:30 PM - 1:30 PM GMT | Lunch

NOV 16, 2023
11am BST

11:30 PM - 2:00 PM GMT | Session 3 - Customer keynote

NOV 16, 2023
2pm BST

2:00 - 4:30 PM GMT | Session 4 – Citeline/Evaluate Commercial Overview

Showcase of the value of analyzing a market from a Standard of Care, Clinical and Financial perspective and bring in data across Strategic Intelligence and put together a case study.

HOSTED BY
  • V Spurr
    Vince Spurr Solution Specialist Team Lead, Citeline
  • Alongside a panel of...
NOV 16, 2023
2pm BST

2:30 PM - 3:25 PM GMT | Session 5 - Customer panel

How Biotech Can Keep Cash Flowing So The Innovation Well Doesn't Run Dry

MODERATOR & PANELISTS
  • K Grogan
    Kevin Grogan Managing Editor, Scrip
  • Olivia Cavlan
    Olivia Cavlan Chief Corporate Development and Strategy Officer, Alchemab Therapeutics
  • Michael Altorfer
    Michael Altorfer CEO, Swiss Biotech Association
  • PANELISTS
    • Olivia Cavlan, Chief Corporate Development and Strategy Officer, Alchemab Therapeutics;
    • Michael Altorfer, CEO, Swiss Biotech Association
NOV 16, 2023
3pm BST

3:25 PM - 3:30 PM GMT | Closing remarks

Hear the event's closing remarks from Duncan Emerton

MODERATOR
  • D Emerton
    Duncan Emerton Vice President, Consulting & Analytics (EMEAI), Citeline
  • Alongside a panel of...
NOV 16, 2023
3pm BST

3:30 PM GMT | End